DM
SRRA

Deerfield Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Deerfield Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-44,122
Closed -$5.22M – 119
2018
Q2 		$5.22M Hold
44,122
– – 0.18% 98
2018
Q1 		$3.65M Buy
44,122
+95
+0.2% +$10.8K 0.13% 100
2017
Q4 		$6.57M Sell
44,027
-25,973
-37% -$2.5M 0.26% 80
2017
Q3 		$4.34M Sell
70,000
-17,393
-20% -$1.02M 0.2% 81
2017
Q2 		$4.09M Sell
87,393
-36,915
-30% -$1.88M 0.22% 69
2017
Q1 		$7.61M Buy
124,308
+95,143
+326% +$5.53M 0.29% 79
2016
Q4 		$1.74M Sell
29,165
-5,513
-16% -$344K 0.07% 94
2016
Q3 		$2.52M Sell
34,678
-5,540
-14% -$428K 0.12% 77
2016
Q2 		$3.2M Sell
40,218
-34,815
-46% -$6.63M 0.13% 80
2016
Q1 		$20.2M Buy
75,033
+30,252
+68% +$9.66M 0.86% 42
2015
Q4 		$26.9M Buy
44,781
+11,071
+33% +$7.49M 1.09% 38
2015
Q3 		$27.7M Buy
+33,710
New +$38M 1.07% 35

Other funds holding SRRA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Deerfield Management's SRRA Position: Q3 2018 in Review

Deerfield Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2018, closing a stake of 44,122 shares — an estimated $5.22M sold.

Deerfield Management first reported a position in SRRA in Q3 2015 and held it in 12 quarters. The position peaked at $27.7M in Q3 2015. 60 funds tracked by Wall St. Rank hold SRRA as of Q3 2018.

  • Deerfield Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Deerfield Management sold 44,122 Sierra Oncology, Inc. Common Stock shares in Q3 2018, an estimated $5.22M.
  • Deerfield Management first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2015 and held it in 12 quarters.
  • Deerfield Management's Sierra Oncology, Inc. Common Stock position peaked at $27.7M in Q3 2015.
  • 60 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2018.

Based on Deerfield Management's 13F filing for Q3 2018, filed 14 Nov 2018.